This suggest that HSP90 inhibitors act differently on diverse cell lines, exerting unique cellular responses and underscoring again the importance of a cell-specific proteomic evaluation in IPF. The gene discussed is HSP90AA1; the disease is idiopathic pulmonary fibrosis.